Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Amortizatization of Intangibles came in at $6.1 million in Q2 2026, down 17.95% on a YoY basis from $7.5 million in Q2 2025, and down 13.65% quarter-over-quarter from $7.1 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Amortizatization of Intangibles for 5 consecutive years, with $6.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortizatization of Intangibles fell 17.95% year-over-year to $6.1 million; the trailing twelve-month figure through Jun 2026 stood at $28.5 million (down 4.74% YoY), and the FY2025 full-year result was $30.1 million, up 7.07% from the prior year.
- Amortizatization of Intangibles retreated to $6.1 million in Q2 2026 per DNA's latest filing, from $7.1 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $10.9 million in Q3 2022 and bottomed at $3.7 million in Q4 2023.
- Historically, Amortizatization of Intangibles has averaged $7.4 million across 5 years, with a median of $7.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles sank 48.95% in 2023, then jumped 103.26% in 2024.
- Over 5 years, Amortizatization of Intangibles stood at $7.2 million in 2022, then plunged by 48.95% to $3.7 million in 2023, then surged by 103.26% to $7.5 million in 2024, then gained by 2.1% to $7.6 million in 2025, then retreated by 19.52% to $6.1 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $6.1 million, $7.1 million, and $7.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 6.05 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 8.91 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.10 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.14 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 120,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.14 Mn |
| Mar 31, 2026 | 7.11 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Jun 30, 2025 | 7.49 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 8.29 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 10.87 Mn |